Press Releases

Below you will find the latest press releases from Evolva. You are also welcome to dive into the archive and browse our press releases from there as well:

Latest Press Releases

Reinach, Switzerland, 17 December 2014 – Evolva Holding SA (“Evolva”, SIX: EVE) today announced that Emergent BioSolutions Inc. (“Emergent”, NYSE: EBS) has acquired Evolva’s anti-bacterial programme, the EV-035 series.

Reinach, Switzerland, 16 December 2014 – Evolva Holding SA (SIX: EVE), today announces the completion of the acquisition of Allylix, Inc., after which Allylix will be a wholly-owned subsidiary of Evolva. This acquisition was announced on 18 November 2014.

Reinach, Switzerland, 11 December 2014 – Evolva Holding SA (SIX: EVE) today announces the signing of a binding term sheet for an exclusive collaboration with Takasago International Corporation, Japan.

Expands product portfolio and strengthens stevia franchise

Cargill to increase stake in Evolva

Evolva and Cargill are pioneering the production of great tasting, next-generation sweeteners via fermentation

Reinach, Switzerland, 14 August 2014 – Evolva Holding SA (SIX: EVE) today announces it has entered into a contract (HDTRA1-14-C-0122) with the US Defense Threat Reduction Agency (DTRA)

Reinach, Switzerland, 4 August 2014 – Evolva Holding SA (SIX: EVE) today announces the acquisition of Cambridge, UK based Prosarix Ltd., a leading in silico (computational) modelling company.

Reinach, Switzerland, 28 May 2014 – Evolva Holding SA (SIX: EVE) today announces the start of commercial production of its resveratrol ingredient.

Contact Information

Evolva SA
Duggingerstrasse 23
CH-4153 Reinach
Switzerland
Tel: +41 61 485 2000
Fax: +41 61 485 2001
Evolva A/S
Lersoe Parkallé 42-44
DK-2100 Copenhagen OE
Denmark
Tel: +45 35 200 230
Fax: +45 35 200 231
Evolva Biotech Private Limited
401 - 405, 4th Floor
Ticel Bio Park Ltd
Taramani Road, Taramani
Chennai 600 113
Tamil Nadu, India
Tel: +91 44 4297 1050
Fax: +91 44 4297 1060
Evolva, Inc. (Evolva USA)
2440 Embarcadero Way
Palo Alto
CA 94303
USA
Tel: +1 650 856 2436
Fax: +1 650 856 7950

General Enquiries: info@evolva.com • Business Enquiries: busdev@evolva.com • India Enquiries: info_india@evolva.com